Roche Holding AG
DUS:RHO5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Roche Holding AG
DUS:RHO5
|
CH |
|
Z
|
Zurich Insurance Group AG
XHAM:ZFIN
|
CH |
|
N
|
Netflix Inc
MIL:NFLX
|
US |
|
Goldman Sachs Group Inc
LSE:0R3G
|
US |
|
B
|
British American Tobacco PLC
XHAM:BMT
|
UK |
|
B
|
Bayer AG
F:BAYA
|
DE |
Wall St Price Targets
RHO5 Price Targets Summary
Roche Holding AG
According to Wall Street analysts, the average 1-year price target for RHO5 is 340.93 EUR with a low forecast of 215.68 EUR and a high forecast of 417.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RHO5's stock price target?
Price Target
340.93
EUR
According to Wall Street analysts, the average 1-year price target for RHO5 is 340.93 EUR with a low forecast of 215.68 EUR and a high forecast of 417.25 EUR.
What is the Revenue forecast for Roche Holding AG?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Roche Holding AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Roche Holding AG?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.
